Rinite não alérgica

Referências

Principais artigos

Nassef M, Shapiro G, Casale TB. Identifying and managing rhinitis and its subtypes: allergic and non-allergic components - a consensus report and materials from the Respiratory Allergic Disease Foundation. Curr Med Res Opin. 2006 Dec;22(12):2541-8. Resumo

Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998 Nov;81(5 Pt 2):478-518. Resumo

Brandt D, Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann Allergy Asthma Immunol. 2006;96:526-532. Resumo

Bernstein JA, Levin LS, Al-Shuik E, et al. Clinical characteristics of chronic rhinitis patients with high vs low irritant trigger burdens. Ann Allergy Asthma Immunol. 2012;109:173-178. Resumo

Artigos de referência

1. Kaliner MA, Baraniuk JN, Benninger M, et al. Consensus definition of nonallergic rhinopathy, previously referred to as vasomotor rhinitis, nonallergic rhinitis, and/or idiopathic rhinitis. World Allergy Organ J. 2009 Jun 15;2(6):119-20.Texto completo  Resumo

2. Nassef M, Shapiro G, Casale TB. Identifying and managing rhinitis and its subtypes: allergic and non-allergic components - a consensus report and materials from the Respiratory Allergic Disease Foundation. Curr Med Res Opin. 2006 Dec;22(12):2541-8. Resumo

3. Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998 Nov;81(5 Pt 2):478-518. Resumo

4. Scadding GK, Kariyawasam HH, Scadding G, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (rev ed 2017). Clin Exp Allergy. 2017 Jul;47(7):856-89.Texto completo  Resumo

5. Settipane RA. Demographics and epidemiology of allergic and nonallergic rhinitis. Allergy Asthma Proc. 2001;22:185-189. Resumo

6. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol. 2001;86:494-508. Resumo

7. Baraniuk JN, Kaliner MA. Neuropeptides and nasal secretion. J Allergy Clin Immunol. 1990 Oct;86(4 Pt 2):620-7. Resumo

8. Garay R. Mechanisms of vasomotor rhinitis. Allergy. 2004;59 Suppl 76:4-9; discussion 9-10. Resumo

9. Bernstein JA, Singh U. Neural abnormalities in nonallergic rhinitis. Curr Allergy Asthma Rep. 2015 Apr;15(4):18. Resumo

10. Bernstein JA, Hastings L, Boespflug EL, et al. Alteration of brain activation patterns in nonallergic rhinitis patients using functional magnetic resonance imaging before and after treatment with intranasal azelastine. Ann Allergy Asthma Immunol. 2011 Jun;106(6):527-32. Resumo

11. Bernstein JA, Davis BP, Picard JK, et al. A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. Ann Allergy Asthma Immunol. 2011 Aug;107(2):171-8. Resumo

12. Singh U, Bernstein JA. Intranasal capsaicin in management of nonallergic (vasomotor) rhinitis. Prog Drug Res. 2014;68:147-70. Resumo

13. Singh U, Bernstein JA, Haar L, et al. Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis. Am J Rhinol Allergy. 2014 May-Jun;28(3):215-24. Resumo

14. Powe DG, Huskisson RS, Carney AS, et al. Mucosal T-cell phenotypes in persistent atopic and nonatopic rhinitis show an association with mast cells. Allergy. 2004 Feb;59(2):204-12. Resumo

15. Terada N, Konno A, Fukuda S, et al. Interleukin-5 upregulates intercellular adhesion molecule-1 gene expression in the nasal mucosa in nasal allergy but not in nonallergic rhinitis. Int Arch Allergy Immunol. 1995 Feb;106(2):139-45. Resumo

16. Demoly P, Sahla M, Campbell AM, et al. ICAM-1 expression in upper respiratory mucosa is differentially related to eosinophil and neutrophil inflammation according to the allergic status. Clin Exp Allergy. 1998 Jun;28(6):731-8. Resumo

17. Brandt D, Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann Allergy Asthma Immunol. 2006;96:526-532. Resumo

18. Bernstein JA, Levin LS, Al-Shuik E, et al. Clinical characteristics of chronic rhinitis patients with high vs low irritant trigger burdens. Ann Allergy Asthma Immunol. 2012;109:173-178. Resumo

19. Meltzer EO, Orgel HA, Rogenes PR, et al. Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate. J Allergy Clin Immunol. 1994 Oct;94(4):708-15. Resumo

20. Bernstein JA, Salapatek AM, Lee JS, et al. Provocation of nonallergic rhinitis subjects in response to simulated weather conditions using an environmental exposure chamber model. Allergy Asthma Proc. 2012 Jul-Aug;33(4):333-40. Resumo

21. Meltzer EO, Nathan RA, Derebery J, et al. Physician perceptions of the treatment and management of allergic and nonallergic rhinitis. Allergy Asthma Proc. 2009 Jan-Feb;30(1):75-83. Resumo

22. Staevska M, Baraniuk JN. Persistent nonallergic rhinosinusitis. Curr Allergy Asthma Rep. 2005 May;5(3):233-42. Resumo

23. Campo P, Rondón C, Gould HJ, et al. Local IgE in non-allergic rhinitis. Clin Exp Allergy. 2015 May;45(5):872-81. Resumo

24. Sur DKC, Plesa ML. Chronic nonallergic rhinitis. Am Fam Physician. 2018 Aug 1;98(3):171-76. Resumo

25. Spector SL. The placebo effect is nothing to sneeze at. J Allergy Clin Immunol. 1992 Dec;90(6 Pt 2):1042-3. Resumo

26. LaForce CF, Corren J, Wheeler WJ, et al. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. Ann Allergy Asthma Immunol. 2004 Aug;93(2):154-9. Resumo

27. Berger WE, White MV. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. Ann Allergy Asthma Immunol. 2003 Aug;91(2):205-11. Resumo

28. Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol. 2001 Jan;86(1):28-35. Resumo

29. Ciprandi G. Treatment of nonallergic perennial rhinitis. Allergy. 2004;59 Suppl 76:16-22; discussion 22-3. Resumo

30. Bernstein JA. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability. Curr Med Res Opin. 2007 Oct;23(10):2441-52. Resumo

31. Kaliner MA. A novel and effective approach to treating rhinitis with nasal antihistamines. Ann Allergy Asthma Immunol. 2007 Nov;99(5):383-90; quiz 391-2, 418. Resumo

32. Dockhorn R, Aronson D, Bronsky E, et al. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol. 1999 Apr;82(4):349-59. Resumo

33. Scadding GK, Lund VJ, Jacques LA, et al. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy. 1995 Aug;25(8):737-43. Resumo

34. Swierczynska M, Strek P, Skladzien J, et al. Nonallergic rhinitis with eosinophilia syndrome: state of knowledge. Otolaryngol Pol. 2003;57(1):81-4. Resumo

35. Meltzer EO. The pharmacological basis for the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids. Allergy. 1997;52(36 Suppl):33-40. Resumo

36. Balle VH, Pedersen U, Engby B. Allergic perennial and non-allergic, vasomotor rhinitis treated with budesonide nasal spray. Rhinology. 1980 Sep;18(3):135-42. Resumo

37. Georgitis JW, Banov C, Boggs PB, et al. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. Clin Exp Allergy. 1994 Nov;24(11):1049-55. Resumo

38. Bronsky EA, Druce H, Findlay SR, et al. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol. 1995 May;95(5 pt 2):1117-22. Resumo

39. Hellings PW, Klimek L, Cingi C, et al. Non-allergic rhinitis: Position Paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017 Jun 2;72(11):1657-65.Texto completo  Resumo

40. Vaidyanathan S, Williamson P, Clearie K, et al. Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion. Am J Respir Crit Care Med. 2010 Jul 1;182(1):19-24.Texto completo  Resumo

41. Baroody FM, Brown D, Gavanescu L, et al. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011 Apr;127(4):927-34.Texto completo  Resumo

42. Sandhu AS, Temple RH, Timms MS. Partial laser turbinectomy: two year outcomes in patients with allergic and non-allergic rhinitis. Rhinology. 2004 Jun;42(2):81-4. Resumo

43. Mladina R, Risavi R, Subaric M. CO2 laser anterior turbinectomy in the treatment of non-allergic vasomotor rhinopathia. A prospective study upon 78 patients. Rhinology. 1991 Dec;29(4):267-71. Resumo

44. Gevorgyan A, Segboer C, Gorissen R, et al. Capsaicin for non-allergic rhinitis. Cochrane Database Syst Rev. 2015 Jul 14;(7):CD010591.Texto completo  Resumo

45. Van Gerven L, Alpizar YA, Wouters MM, et al. Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis. J Allergy Clin Immunol. 2014 May;133(5):1332-9, 1339. Resumo

46. Holland C, van Drunen C, Denyer J, et al. Inhibition of capsaicin-driven nasal hyper-reactivity by SB-705498, a TRPV1 antagonist. Br J Clin Pharmacol. 2014 May;77(5):777-88. Resumo

47. Murdoch RD, Bareille P, Denyer J, et al. TRPV1 inhibition does not prevent cold dry air-elicited symptoms in non-allergic rhinitis. Int J Clin Pharmacol Ther. 2014 Apr;52(4):267-76. Resumo

48. Lieberman P, Meltzer EO, LaForce CF, et al. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis. Allergy Asthma Proc. 2011 Mar-Apr;32(2):151-8.Texto completo  Resumo

49. Ozcan C, Ismi O. Botulinum toxin for rhinitis. Curr Allergy Asthma Rep. 2016 Aug;16(8):58. Resumo

50. Juto JE, Axelsson M. Kinetic oscillation stimulation as treatment of non-allergic rhinitis: an RCT study. Acta Otolaryngol. 2014 May;134(5):506-12.Texto completo  Resumo

51. Deenadayal DS, Kumar MN, Sudhakshin P, et al. Radiofrequency reduction of inferior turbinates in allergic and non allergic rhinitis. Indian J Otolaryngol Head Neck Surg. 2014 Jan;66(Suppl 1):231-6. Resumo

52. Schreiber CP, Hutchinson S, Webster CJ, et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache. Arch Intern Med. 2004 Sep 13;164(16):1769-72. Resumo

53. Bernstein JA, Fox RW, Martin VT, et al. Headache and facial pain: differential diagnosis and treatment. J Allergy Clin Immunol Pract. 2013 May-Jun;1(3):242-51. Resumo

54. Martin VT, Fanning KM, Serrano D, et al. Chronic rhinitis and its association with headache frequency and disability in persons with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Cephalalgia. 2014 Apr;34(5):336-48. Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal